TABLE 1.
Clinical characteristics of enrolled patients whose samples were collected and further processed for microbiota sequencinga
| Variables | RSA (n = 25) | CON (n = 25) | P value |
|---|---|---|---|
| Basic information | |||
| Age (yrs) | 32.56 ± 3.50 | 31.60 ± 3.49 | 0.336 |
| BMI (kg/m2) | 22.19 ± 3.49 | 21.46 ± 2.93 | 0.429 |
| Menstrual cycle | 28.34 ± 2.85 | 29.44 ± 2.51 | 0.154 |
| Basal sex hormone level | |||
| FSH (mIU/mL) | 4.17 ± 3.50 | 4.10 ± 3.85 | 0.947 |
| LH (mIU/mL) | 4.00 ± 3.29 | 4.09 ± 2.97 | 0.922 |
| P (nmol/L) | 29.40 ± 13.72 | 29.80 ± 16.94 | 0.927 |
| E2 (pmol/L） | 484.75 ± 346.62 | 369.40 ± 194.10 | 0.155 |
| AMH (ng/mL） | 3.34 ± 2.17 | 3.07 ± 1.65 | 0.638 |
| Chronic endometritis | 13 (52.0%) | 6 (24.0%) | 0.041* |
a
BMI: body mass index; FSH: follicle-stimulating hormone; LH: luteinizing hormone; P: progesterone; E2: estrogen; AMH: anti-mullerian hormone. * P <0.05.